Friday, January 3, 2020

Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Mirtazapine Tablets Lot Number 03119002A3 Due to Label Error on Declared Strength


The Center for Veterinary Medicine is sending this announcement since these tablets are commonly used in veterinary medicine.

Aurobindo Pharma USA, Inc. is voluntarily recalling lot number 03119002A3 of Mirtazapine Tablets to the consumer level. The product is being recalled due to a label error on declared strength; bottles labeled as Mirtazapine 7.5 mg may contain 15 mg tablets.
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)